Jamie N. Hadac, Ph.D. - Related publications

2014 Cancer Biology University of Wisconsin, Madison, Madison, WI 
Genetics, Molecular Biology, Oncology, Public Health
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2019 Padhye A, Ungewiss C, Fradette JJ, Rodriguez BL, Albritton JL, Miller JS, Gibbons DL. A novel ex vivo tumor system identifies Src-mediated invasion and metastasis in mesenchymal tumor cells in non-small cell lung cancer. Scientific Reports. 9: 4819. PMID 30894630 DOI: 10.1038/s41598-019-41301-2   
2019 McCoach CE, Bivona TG. Engineering Multidimensional Evolutionary Forces to Combat Cancer. Cancer Discovery. PMID 30992280 DOI: 10.1158/2159-8290.CD-18-1196   
2019 Katayama Y, Uchino J, Chihara Y, Tamiya N, Kaneko Y, Yamada T, Takayama K. Tumor Neovascularization and Developments in Therapeutics. Cancers. 11. PMID 30845711 DOI: 10.3390/cancers11030316   
2019 Zhao M, Guo W, Wu Y, Yang C, Zhong L, Deng G, Zhu Y, Liu W, Gu Y, Lu Y, Kong L, Meng X, Xu Q, Sun Y. SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade. Acta Pharmaceutica Sinica. B. 9: 304-315. PMID 30972278 DOI: 10.1016/j.apsb.2018.08.009   
2019 Miyamoto H, Kunisaki C, Sato S, Tanaka Y, Sato K, Kosaka T, Yukawa N, Akiyama H, Saigusa Y, Endo I. Tumor Volume Index as a Prognostic Factor in Patients after Curative Esophageal Cancer Resection. Annals of Surgical Oncology. PMID 30891629 DOI: 10.1245/s10434-019-07308-9   
2019 Lankadasari MB, Mukhopadhyay P, Mohammed S, Harikumar KB. TAMing pancreatic cancer: combat with a double edged sword. Molecular Cancer. 18: 48. PMID 30925924 DOI: 10.1186/s12943-019-0966-6   
2019 Banerjee A, Chabria Y, Kanna N R R, Gopi J, Rowlo P, Sun XF, Pathak S. Role of Tumor Specific niche in Colon Cancer Progression and Emerging Therapies by Targeting Tumor Microenvironment. Advances in Experimental Medicine and Biology. PMID 30969400 DOI: 10.1007/5584_2019_355   
2019 Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, Liu Q, Dou R, Xiong B. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Molecular Cancer. 18: 64. PMID 30927925 DOI: 10.1186/s12943-019-0976-4   
2019 Truong DD, Kratz A, Park JG, Barrientos ES, Saini H, Nguyen T, Pockaj B, Mouneimne G, LaBaer J, Nikkhah M. A human organotypic microfluidic tumor model permits investigation of the interplay between patient-derived fibroblasts and breast cancer cells. Cancer Research. PMID 30992322 DOI: 10.1158/0008-5472.CAN-18-2293   
2019 Sedighi M, Zahedi Bialvaei A, Hamblin MR, Ohadi E, Asadi A, Halajzadeh M, Lohrasbi V, Mohammadzadeh N, Amiriani T, Krutova M, Amini A, Kouhsari E. Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities. Cancer Medicine. PMID 30950210 DOI: 10.1002/cam4.2148   
2019 Kok JL, Teepen JC, van der Pal HJ, van Leeuwen FE, Tissing WJE, Neggers SJCMM, Loonen JJ, Louwerens M, Versluys B, van den Heuvel-Eibrink MM, van Dulmen-den Broeder E, Jaspers MMW, van Santen HM, van der Heiden-van der Loo M, Janssens GO, ... , et al. Incidence of and Risk Factors for Histologically Confirmed Solid Benign Tumors Among Long-term Survivors of Childhood Cancer. Jama Oncology. PMID 30920605 DOI: 10.1001/jamaoncol.2018.6862   
2019 Conway GD, Buzza MS, Martin EW, Duru N, Johnson TA, Peroutka RJ, Pawar NR, Antalis TM. PRSS21/testisin inhibits ovarian tumor metastasis and antagonizes proangiogenic angiopoietins ANG2 and ANGPTL4. Journal of Molecular Medicine (Berlin, Germany). PMID 30911775 DOI: 10.1007/s00109-019-01763-3   
2019 Jiang Z, Liu Z, Li M, Chen C, Wang X. Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment. Ebiomedicine. PMID 30935888 DOI: 10.1016/j.ebiom.2019.03.068   
2019 Wagner J, Rapsomaniki MA, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, Rees M, Ramaswamy A, Muenst S, Soysal SD, Jacobs A, Windhager J, Silina K, van den Broek M, Dedes KJ, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. PMID 30982598 DOI: 10.1016/j.cell.2019.03.005   
2019 Sankaralingam S, Kumar B, Shishodia G, Koul S, Koul H. Reactive Oxygen Species and Cancer: A complex interaction. Cancer Letters. PMID 30905813 DOI: 10.1016/j.canlet.2019.03.020   
2019 Wylie B, Macri C, Mintern JD, Waithman J. Dendritic Cells and Cancer: From Biology to Therapeutic Intervention. Cancers. 11. PMID 30979057 DOI: 10.3390/cancers11040521   
2019 Burz C, Rosca A, Pop VV, Buiga R, Aldea C, Samasca G, Silaghi C, Sur D, Lupan I, Pricopie A. Liquid biopsy challenge and hope in colorectal cancer. Expert Review of Molecular Diagnostics. 19: 341-348. PMID 30943811 DOI: 10.1080/14737159.2019.1597708   
2019 Lu X, Meng T. Depletion of tumor-associated macrophages enhances the anti-tumor effect of docetaxel in a murine epithelial ovarian cancer. Immunobiology. PMID 30926154 DOI: 10.1016/j.imbio.2019.03.002   
2019 Chen N, Ritsma LMA, Vrisekoop N. In vivo characteristics of human and mouse breast tumor cell lines. Experimental Cell Research. PMID 30980788 DOI: 10.1016/j.yexcr.2019.04.009   
2019 Mansouri S, Hesari PM, Naghavi-Al-Hosseini F, Majidzadeh-A K, Farahmand L. The Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer Prior to any Systematic Therapy: A Systematic Review. Current Stem Cell Research & Therapy. PMID 30843493 DOI: 10.2174/1574888X14666190306103759   
2019 Ryu JS, Lim JH, Lee MK, Lee SJ, Kim HJ, Kim MJ, Park MH, Kim JS, Nam HS, Park N, Yong SJ. Feasibility of Bronchial Washing Fluid-Based Approach to Early-Stage Lung Cancer Diagnosis. The Oncologist. PMID 31036768 DOI: 10.1634/theoncologist.2019-0147   
2019 Volz J, Mammadova-Bach E, Gil-Pulido J, Nandigama R, Remer K, Sorokin L, Zernecke A, Abrams SI, Ergün S, Henke E, Nieswandt B. Inhibition of platelet GPVI induces intratumor hemorrhage and increases efficacy of chemotherapy in mice. Blood. PMID 30952674 DOI: 10.1182/blood.2018877043   
2019 Wu T, Wu X, Wang HY, Chen L. Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer. Cancer Communications (London, England). 39: 21. PMID 30999966 DOI: 10.1186/s40880-019-0365-9   
2019 Forsythe S, Mehta N, Devarasetty M, Sivakumar H, Gmeiner W, Soker S, Votanopoulos K, Skardal A. Development of a Colorectal Cancer 3D Micro-tumor Construct Platform From Cell Lines and Patient Tumor Biospecimens for Standard-of-Care and Experimental Drug Screening. Annals of Biomedical Engineering. PMID 31020445 DOI: 10.1007/s10439-019-02269-2   
2019 Künzel J, Gribko A, Lu Q, Stauber RH, Wünsch D. Nanomedical detection and downstream analysis of circulating tumor cells in head and neck patients. Biological Chemistry. PMID 30903749 DOI: 10.1515/hsz-2019-0141   
2019 Seo I, Cho JH, Lee MH, Park WJ, Kwon SY, Lee JH. Clinical and Prognostic Value of Human Mammary Tumor Virus in Korean Patients with Breast Carcinoma. Annals of Clinical and Laboratory Science. 49: 171-174. PMID 31028060   
2019 Eckert F, Zwirner K, Boeke S, Thorwarth D, Zips D, Huber SM. Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors. Frontiers in Immunology. 10: 407. PMID 30930892 DOI: 10.3389/fimmu.2019.00407   
2019 Huang Q, Chen Z, Cheng P, Huang Y, Wang Z, Jiang Z, Yang C, Pan J, Qiu F, Huang J. LYRM2 directly Regulates Complex I Activity to Support Tumor Growth in Colorectal Cancer by Oxidative Phosphorylation. Cancer Letters. PMID 31004700 DOI: 10.1016/j.canlet.2019.04.021   
2019 Kang H, Kim H, Lee S, Youn H, Youn B. Role of Metabolic Reprogramming in Epithelial⁻Mesenchymal Transition (EMT). International Journal of Molecular Sciences. 20. PMID 31027222 DOI: 10.3390/ijms20082042   
2019 Prahallad A, Jensen MR, Chapeau EA. Deciphering mechanisms of response and resistance in large-scale mouse cancer screens. Current Opinion in Genetics & Development. 54: 48-54. PMID 30954760 DOI: 10.1016/j.gde.2019.02.006   
2019 Liu X, Zhu L, Wang R, Lou X, Yao X, Ni C, Qin Z. IFNγ inhibits fibroblast-leading tumor cell invasion through downregulating N-cadherin. Biochemical and Biophysical Research Communications. PMID 30914199 DOI: 10.1016/j.bbrc.2019.03.136   
2019 Taylor WR, Fedorka SR, Gad I, Shah R, Alqahtani HD, Koranne R, Kuganesan N, Dlamini S, Rogers T, Al-Hamashi A, Kholodovych V, Barudi Y, Junk D, Rashid MS, Jackson MW, et al. Small-Molecule Ferroptotic Agents with Potential to Selectively Target Cancer Stem Cells. Scientific Reports. 9: 5926. PMID 30976078 DOI: 10.1038/s41598-019-42251-5   
2019 Trpkov K, Bonert M, Gao Y, Kapoor A, He H, Yilmaz A, Gill AJ, Williamson SR, Comperat E, Tretiakova M, Magi-Galluzzi C, Brimo F, Hes O. High-grade Oncocytic Tumor (HOT) of Kidney in a Patient with Tuberous Sclerosis Complex. Histopathology. PMID 31002177 DOI: 10.1111/his.13876   
2019 Sullivan MR, Danai LV, Lewis CA, Chan SH, Gui DY, Kunchok T, Dennstedt EA, Vander Heiden MG, Muir A. Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. Elife. 8. PMID 30990168 DOI: 10.7554/eLife.44235   
2019 He Y, Liu ZX, Jiang ZH, Wang XS. Identification of genomic features associated with immunotherapy response in gastrointestinal cancers. World Journal of Gastrointestinal Oncology. 11: 270-280. PMID 31040893 DOI: 10.4251/wjgo.v11.i4.270   
2019 Agarwal R, Khurana N, Singh T, Agarwal PN. Tumor budding in infiltrating breast carcinoma: Correlation with known clinicopathological parameters and hormone receptor status. Indian Journal of Pathology & Microbiology. 62: 222-225. PMID 30971544 DOI: 10.4103/IJPM.IJPM_120_18   
2019 Vasaikar S, Huang C, Wang X, Petyuk VA, Savage SR, Wen B, Dou Y, Zhang Y, Shi Z, Arshad OA, Gritsenko MA, Zimmerman LJ, McDermott JE, Clauss TR, Moore RJ, ... , et al. Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities. Cell. PMID 31031003 DOI: 10.1016/j.cell.2019.03.030   
2019 Wu L, Saxena S, Awaji M, Singh RK. Tumor-Associated Neutrophils in Cancer: Going Pro. Cancers. 11. PMID 31010242 DOI: 10.3390/cancers11040564   
2019 Lee B, Gibbs P. Inflammation, Biomarkers and Immuno-Oncology Pathways in Pancreatic Cancer. Journal of Personalized Medicine. 9. PMID 31035449 DOI: 10.3390/jpm9020020   
2019 Peitzsch C, Kurth I, Ebert N, Dubrovska A, Baumann M. Cancer stem cells in radiation response: current views and future perspectives in radiation oncology. International Journal of Radiation Biology. 1-42. PMID 30897014 DOI: 10.1080/09553002.2019.1589023   
2019 van der Heijden M, Miedema DM, Waclaw B, Veenstra VL, Lecca MC, Nijman LE, van Dijk E, van Neerven SM, Lodestijn SC, Lenos KJ, de Groot NE, Prasetyanti PR, Arricibita Varea A, Winton DJ, Medema JP, et al. Spatiotemporal regulation of clonogenicity in colorectal cancer xenografts. Proceedings of the National Academy of Sciences of the United States of America. PMID 30850544 DOI: 10.1073/pnas.1813417116   
2019 Kim TS, da Silva E, Coit DG, Tang LH. Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype. The American Journal of Surgical Pathology. PMID 30969179 DOI: 10.1097/PAS.0000000000001253   
2019 Zhang Y, Zhao Y, Shen J, Sun X, Liu Y, Liu H, Wang Y, Wang J. Nano-Enabled Modulation of Acidic Tumor Microenvironment Reverses Anergy of Infiltrating T Cells and Potentiates Anti-PD-1 Therapy. Nano Letters. PMID 30943039 DOI: 10.1021/acs.nanolett.8b04296   
2019 Yunus M, Jansson PJ, Kovacevic Z, Kalinowski DS, Richardson DR. Tumor-induced neoangiogenesis and receptor tyrosine kinases - Mechanisms and strategies for acquired resistance. Biochimica Et Biophysica Acta. General Subjects. PMID 31029846 DOI: 10.1016/j.bbagen.2019.04.017   
2019 Baxevanis CN, Sofopoulos M, Fortis SP, Perez SA. The role of immune infiltrates as prognostic biomarkers in patients with breast cancer. Cancer Immunology, Immunotherapy : Cii. PMID 30905043 DOI: 10.1007/s00262-019-02327-7   
2019 Wang Y, Zhao C, Chang L, Jia R, Liu R, Zhang Y, Gao X, Li J, Chen R, Xia X, Bulbul A, Husain H, Guan Y, Yi X, Xu J. Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer. Ebiomedicine. PMID 31031019 DOI: 10.1016/j.ebiom.2019.04.003   
2019 Singh M, Tian XJ, Donnenberg VS, Watson AM, Zhang J, Stabile LP, Watkins SC, Xing J, Sant S. Targeting the temporal dynamics of hypoxia-induced tumor-secreted factors halts tumor migration. Cancer Research. PMID 30952634 DOI: 10.1158/0008-5472.CAN-18-3151   
2019 Bilgin B, Sendur MAN, Hizal M, Dede DS, Akinci MB, Kandil SU, Yaman S, Yalçin A, Kiliç M, Yalçin B. Prognostic effect of red cell distribution width-to-platelet ratio in colorectal cancer according to tumor stage and localization. Journal of Cancer Research and Therapeutics. 15: 54-60. PMID 30880755 DOI: 10.4103/jcrt.JCRT_624_17   
2019 McDonald KA, Kawaguchi T, Qi Q, Peng X, Asaoka M, Young J, Opyrchal M, Yan L, Patnaik S, Otsuji E, Takabe K. Tumor Heterogeneity Correlates with Less Immune Response and Worse Survival in Breast Cancer Patients. Annals of Surgical Oncology. PMID 30963401 DOI: 10.1245/s10434-019-07338-3   
2019 Morgensztern D, Ko A, O'Brien M, Ong TJ, Waqar SN, Socinski MA, Postmus PE, Bhore R. Association between depth of response and survival in patients with advanced-stage non-small cell lung cancer treated with first-line chemotherapy. Cancer. PMID 30933354 DOI: 10.1002/cncr.32114